Integrative screening identifies functional variants and VNTRs underlying GWAS signals at the 5p15.33 multi-cancer susceptibility locus
Aidan O’BrieniD, Hyunkyung Kong, Harsh PateliD, Michelle HoiD, Minal B. PateliD, Jun ZhongiD, Mai XuiD, Brenen W. PapenbergiD, Katelyn E. ConnellyiD, Irene J. CollinsiD, Rebecca C. HennesseyiD, Rohit ThakuriD, Hayley SowardsiD, Karen M. Funderburk, Thong LuongiD, Oscar Flórez-VargasiD, Timothy MyersiD, Ashley A. JermusykiD, Bryan Gorman, Wen LuoiD, Kristine M. JonesiD, Sudipto DasiD, The Pancreatic Cancer Cohort and Case-Control Consortia (PanScan/PanC4), Qing Lan BiD, Nathaniel RothmaniD, , Laufey Thora AmundadottiriD
Abstract
Chromosome 5p15.33 harbors several independent association signals which demonstrate antagonistic pleiotropy across cancer types, with causal mechanisms largely unresolved. To identify functional variants and enhancer elements at this locus, we performed statistical fine-mapping followed by massively parallel reporter assays (MPRA) and proliferation based CRISPRi screens. This approach identified eight multi-cancer functional variants (MCFVs) across three GWAS signals. Targeting rs421629 (part of the CLPTM1L signal marked by rs465498) with CRISPRi revealed opposing effects on TERT expression in pancreatic versus lung cancer cells, consistent with the antagonistic pleiotropy observed for this signal. Furthermore, CRISPRi nominated an intronic CLPTM1L variable number tandem repeat (VNTR) as a potent enhancer. Long-read sequencing established VNTR polymorphisms as potential causal variants for the rs465498 signal. We showed that Hippo-pathway transcription factors mediate VNTR enhancer activity in lung and pancreatic cancer cells. Together, these findings indicate that cancer susceptibility at 5p15.33 may be mediated by both SNPs and VNTRs and provide an integrated framework for resolving complex pleiotropic loci.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genetic regulation of TERT splicing contributes to reduced or elevated cancer risk by altering cellular longevity and replicative potential
Oscar Flórez-Vargas, Michelle Ho, … Ludmila Prokunina‐Olsson·medRxiv·Nov 4, 2024
- Large-scale association study identifies lung cancer susceptibility copy number variants and their potential functional role in genetic instability
Feifei Xiao, Fei Qin, … Christopher Ian Amos·Cancer Epidemiology Biomarkers & PreventionPeer-reviewed·Oct 19, 2026
- Functional characterization of a multi-cancer risk locus on chromosome band 2q33.1 near CASP8
Hyunkyung Kong, Jiyeon Choi, … Kevin M. Brown·bioRxiv·Jan 6, 2026
- Transcriptome and interactome analyses identify the TP53 interacting gene RCCD1 as a candidate susceptibility gene at the 15p26.1 breast and ovarian cancer risk locus
Jasmine Plummer, Felipe Segato Dezem, … Simon A. Gayther·bioRxiv·Sep 29, 2020
- Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression and drug response
P. Zhang, I. Kitchen-Smith, … G. Bond·bioRxiv·Nov 9, 2019
- Context-aware single-cell multiome approach identified cell-type specific lung cancer susceptibility genes
Erping Long, Jinhu Yin, … Jiyeon Choi·Nature CommunicationsPeer-reviewed·Sep 12, 2024